Xavier Montalban

St
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 606 publications

A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.

A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 22, 2026

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

Journal: Neurology
Published: August 20, 2026

Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.

Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 04, 2026

Towards a biologically informed description of multiple sclerosis disease course - a roadmap for transition.

Towards a biologically informed description of multiple sclerosis disease course - a roadmap for transition.

Journal: Nature reviews. Neurology
Published: July 09, 2026

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Journal: Nature medicine
Published: July 09, 2026

Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated States.

Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated States.

Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026

Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald Criteria: Disparities and Opportunity.

Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald Criteria: Disparities and Opportunity.

Journal: Neurology. Clinical practice
Published: June 26, 2026

Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.

Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.

Journal: Neurology and therapy
Published: June 01, 2026

Rethinking multiple sclerosis therapy beyond clinical phenotypes.

Rethinking multiple sclerosis therapy beyond clinical phenotypes.

Journal: Brain : a journal of neurology
Published: June 01, 2026

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity.

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity.

Journal: JAMA network open
Published: May 20, 2026

Evaluation of the 2022 international consensus criteria for optic neuritis: the role of clinical features and visual evoked potentials.

Evaluation of the 2022 international consensus criteria for optic neuritis: the role of clinical features and visual evoked potentials.

Journal: Journal of neurology
Published: May 17, 2026

Alzheimer's disease polygenic risk score associates with hippocampal subfield atrophy and immune-related genetic mechanism.

Alzheimer's disease polygenic risk score associates with hippocampal subfield atrophy and immune-related genetic mechanism.

Journal: Frontiers in aging neuroscience
Published: May 07, 2026
Showing 1-12 of 606

Last Updated: 09/26/2026